MEMENTO – A Phase 4, Single-arm, Open-label Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Assess the Impact on Myocardial Structure with Cardiac Magnetic Resonance Imaging (CMR)

  • Gutman, Sarah (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date11/11/24 → 10/11/26

Keywords

  • Clinical Trials
  • CV0271088